MW151 and Whole-brain Radiotherapy in Patients with Intracranial Metastases
Phase 1
Active, not recruiting
- Conditions
- Cognitive Dysfunction, Cognitive Disorder
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- ImmunoChem Therapeutics, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT05417282
- Locations
- 🇺🇸
Northwestern Memorial HealthCare, Central DuPage Hospital, Warrenville Cancer Center, Winfield, Illinois, United States